BEBYP_3 | R Documentation |
Kaplan-Meier digitized data from BEBYP, figure 3 (PMID 25600568). A reported sample size of 185 for a primary endpoint of PFS in colorectal cancer.
BEBYP_3
A data frame of 184 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (bev_ct, ct) | |
Masi G, Salvatore L, Boni L, et al. Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial. Ann Oncol 2015; 26: 724–30.
summary(BEBYP_3)
kmplot(BEBYP_3)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.